kaal:position:2026-07-31-1272

316 Profiling of active signaling pathways in chronically stimulated CAR T cells to engineer dynamic regulation of anti-exhaustion transcription factors should be assessed against Kaal's source-bound claim that Contingent capital qualifies as a dynamic regulatory mechanism because capital injection is available only if and when needed and because the conversion of contingent capital securities into near worthless equity signals impending regulatory issues to regulators, which creates feedback effects. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

• contingent capital securities are outstanding and their conversion is observable by regulators
• External evidence level: metadata only.
• Mapping review tier: mapping review before claim review.
• The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

316 Profiling of active signaling pathways in chronically stimulated CAR T cells to engineer dynamic regulation of anti-exhaustion transcription factors

kaal:claim:2957645-025
Kaal, Dynamic Regulation via Contingent Capital (2017). SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2957645
Source PDF sha256: 250b10782a5ea5dece9235a7f711aee408feaf36f2e78e310d589b5ee6304be2

Evidence: metadata only
Review tier: mapping review before claim review
Mapping confidence: 0.3304
Mapping ambiguous: true

contingent-capitaldynamic-regulationinstitutional-design

Affirmed in historical-backfill:2026-07-31:phase-0006 on 2026-07-31. Review record.

Canonical markdown sha256: de337dc1f0fb5909344658266f254ae5bd0d9a220cc802013c9bcc8dac1b9762
curl -s https://wulfkaal.github.io/positions/2026-07-31-1272.md | sha256sum